Forcyte Biotechnologies, Inc

the function-first biology company

Dr. Pushkarsky’s perspective describing FLECS is published in ADT

Dr. Pushkarsky presented the team’s overall work on FLECS Technology at the annual SBI2 meeting in San Diego back in September 2017. He was happy to have been awarded the Presidential Innovation Award and invited to write a short piece about his presentation – last month, this piece was published in the journal ASSAY and Drug Development Technologies!

Link to article is here:

Scroll to Top